Jason Sperry

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Jason Sperry sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 3 currently recruiting 5 completed later-stage tilt top decile by trial count

Jason Sperry: 10 sponsored US clinical trials, 3 recruiting.

Jason Sperry sponsors 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 5 completed. 6 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Traumatic Injury, with 2 trials.

Top-decile sponsor footprint

Jason Sperry ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING Phase 2

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

NCT05958342
RECRUITING Phase 3

Prehospital Analgesia INtervention Trial (PAIN)

NCT05437575
RECRUITING NA

LITES Task Order 0005 Prehospital Airway Control Trial (PACT)

NCT04100564
NOT YET RECRUITING Phase 3

Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial

NCT07212998
COMPLETED Phase 2

Cold Stored Platelet in Hemorrhagic Shock

NCT04667468
COMPLETED Phase 3

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

NCT04684719
COMPLETED Phase 2

Cold-stored Platelet Early Intervention in TBI

NCT04726410
TERMINATED Phase 3

Pragmatic Prehospital Group O Whole Blood Early Resuscitation Trial

NCT03477006
COMPLETED Phase 3

Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)

NCT02086500
COMPLETED Phase 3

PreHospital Air Medical Plasma Trial

NCT01818427

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 3 6

Therapeutic Areas

Traumatic Injury 2
Traumatic Hemorrhage 1
Airway Control 1
Hemorrhagic Shock 1
Trauma Injury 1
Hemorrhage 1
Trauma 1

Where Jason Sperry enrollment is open (later-stage tilt)

3 recruiting of 10 indexed (30% open); 5 completed (50%).

Phase mix: 6 late (III/IV) vs 3 early (I/II) (later-stage heavy).

Top condition: Traumatic Injury (2 trials), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Jason Sperry: open-pipeline peers nationwide

Peers matched on 10 registered trials and 30% open enrollment, not the therapeutic-area sidebar.

Jason Sperry sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30%40% Total trials Recruiting share Jason SperryAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsCentre hospitalier de l'Université de Montréal (CHUM)Child TrendsJacques E. ChellyMedtronic Cardiac Ablation Solutions
Jason Sperry sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Jason Sperry sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 30% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Jason Sperry page

10 registered trials is a research-attention snapshot, not an endorsement of Jason Sperry or any single study.

  • 3 of Jason Sperry's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Traumatic Injury is the condition Jason Sperry studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Traumatic Injury trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Jason Sperry pipeline card: 10 registered trials from official public datasets.Report a data error.